Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Contributed by: Business Wire

Tags

Medical Devices
Health
Health Technology
Research
Science
Biotechnology
pneumonia

More Like This

Viromed Medical AG Seeks Special Approval for Cold Plasma Device for the Prevention of Ventilator-Associated Pneumonia (VAP)

Viromed Medical AG Plans to Acquire All Shares of ActivCell Group AG by Way of a Capital Increase Against Contribution in Kind with Exclusion of Subscription Rights

ColdZyme® certified under the new EU medical device regulation (MDR)

Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat

PR Newswire associated0

Smart Blood Analytics Swiss Achieves EU-MDR Certification for VIRUS vs. BACTERIA Model

e4life: e4ambient and e4you devices (Photo: Business Wire)

“e4life” is Present at Expomed Eurasia with its Innovative Device Able to Inactivate Flu and Covid Viruses With an Efficacy over 90%

BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections

e4life devices (Photo: e4life)

e4life, the New Frontier in the Battle Against Viruses Has Arrived in the United Kingdom Thanks to a Patented Italian Device Which Uses Electromagnetic Waves to Inactivate Them